Prognostic Potential of AKR1B1 in triple-negative breast cancer
This research conducts a thorough bioinformatics examination to explore the possible function of Aldose Reductase (AKR1B1) in Triple - Negative Breast Cancer (TNBC). AKR1B1 displays heterogeneous expression patterns across various cancer types, with notably elevated levels in multiple malignancies s...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2025-01-01
|
| Series: | BIO Web of Conferences |
| Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_02023.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849387337767714816 |
|---|---|
| author | Xiong Jing Liao Xinghua Liu Yimeng Wang Jincheng Fu Yufeng Jiang Shu Guo Hongshan |
| author_facet | Xiong Jing Liao Xinghua Liu Yimeng Wang Jincheng Fu Yufeng Jiang Shu Guo Hongshan |
| author_sort | Xiong Jing |
| collection | DOAJ |
| description | This research conducts a thorough bioinformatics examination to explore the possible function of Aldose Reductase (AKR1B1) in Triple - Negative Breast Cancer (TNBC). AKR1B1 displays heterogeneous expression patterns across various cancer types, with notably elevated levels in multiple malignancies such as bladder urothelial carcinoma, cholangiocarcinoma, and esophageal carcinoma, yet exhibiting lower expression in breast invasive carcinoma (BRCA). Utilizing the UALCAN and Human Protein Atlas (HPA) databases, a detailed analysis of AKR1B1 in BRCA reveals its distinct expression profile. Significantly, our results imply that AKR1B1 could act as a prospective biomarker in triple - negative breast cancer (TNBC). This is due to its connection with survival results and its co - expression network within this specific cancer subtype. Additionally, we delve into the complex interplay between AKR1B1 and the tumor immune microenvironment. We emphasize its notable link with CD8+ T cells and macrophages. Protein network analysis identifies key proteins interacting with AKR1B1, and experimental validation demonstrates the efficacy of curcumin in inhibiting the proliferation of TNBC cells, thereby suggesting its potential as a therapeutic agent targeting AKR1B1. This study establishes a foundational understanding of AKR1B1’s role in TNBC and paves the way for future experimental validation and therapeutic explorations. |
| format | Article |
| id | doaj-art-cbae7f5906e346eab18bb0b1744e4b81 |
| institution | Kabale University |
| issn | 2117-4458 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | EDP Sciences |
| record_format | Article |
| series | BIO Web of Conferences |
| spelling | doaj-art-cbae7f5906e346eab18bb0b1744e4b812025-08-20T03:53:51ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011740202310.1051/bioconf/202517402023bioconf_icbb2025_02023Prognostic Potential of AKR1B1 in triple-negative breast cancerXiong Jing0Liao Xinghua1Liu Yimeng2Wang Jincheng3Fu Yufeng4Jiang Shu5Guo Hongshan6Medical College, Wuhan University of Science and TechnologyCollege of Life Sciences and Health, Wuhan University of Science and TechnologyCollege of Life Sciences and Health, Wuhan University of Science and TechnologyCollege of Life Sciences and Health, Wuhan University of Science and TechnologyCollege of Life Sciences and Health, Wuhan University of Science and TechnologyCollege of Life Sciences and Health, Wuhan University of Science and TechnologyCollege of Life Sciences and Health, Wuhan University of Science and TechnologyThis research conducts a thorough bioinformatics examination to explore the possible function of Aldose Reductase (AKR1B1) in Triple - Negative Breast Cancer (TNBC). AKR1B1 displays heterogeneous expression patterns across various cancer types, with notably elevated levels in multiple malignancies such as bladder urothelial carcinoma, cholangiocarcinoma, and esophageal carcinoma, yet exhibiting lower expression in breast invasive carcinoma (BRCA). Utilizing the UALCAN and Human Protein Atlas (HPA) databases, a detailed analysis of AKR1B1 in BRCA reveals its distinct expression profile. Significantly, our results imply that AKR1B1 could act as a prospective biomarker in triple - negative breast cancer (TNBC). This is due to its connection with survival results and its co - expression network within this specific cancer subtype. Additionally, we delve into the complex interplay between AKR1B1 and the tumor immune microenvironment. We emphasize its notable link with CD8+ T cells and macrophages. Protein network analysis identifies key proteins interacting with AKR1B1, and experimental validation demonstrates the efficacy of curcumin in inhibiting the proliferation of TNBC cells, thereby suggesting its potential as a therapeutic agent targeting AKR1B1. This study establishes a foundational understanding of AKR1B1’s role in TNBC and paves the way for future experimental validation and therapeutic explorations.https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_02023.pdf |
| spellingShingle | Xiong Jing Liao Xinghua Liu Yimeng Wang Jincheng Fu Yufeng Jiang Shu Guo Hongshan Prognostic Potential of AKR1B1 in triple-negative breast cancer BIO Web of Conferences |
| title | Prognostic Potential of AKR1B1 in triple-negative breast cancer |
| title_full | Prognostic Potential of AKR1B1 in triple-negative breast cancer |
| title_fullStr | Prognostic Potential of AKR1B1 in triple-negative breast cancer |
| title_full_unstemmed | Prognostic Potential of AKR1B1 in triple-negative breast cancer |
| title_short | Prognostic Potential of AKR1B1 in triple-negative breast cancer |
| title_sort | prognostic potential of akr1b1 in triple negative breast cancer |
| url | https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_02023.pdf |
| work_keys_str_mv | AT xiongjing prognosticpotentialofakr1b1intriplenegativebreastcancer AT liaoxinghua prognosticpotentialofakr1b1intriplenegativebreastcancer AT liuyimeng prognosticpotentialofakr1b1intriplenegativebreastcancer AT wangjincheng prognosticpotentialofakr1b1intriplenegativebreastcancer AT fuyufeng prognosticpotentialofakr1b1intriplenegativebreastcancer AT jiangshu prognosticpotentialofakr1b1intriplenegativebreastcancer AT guohongshan prognosticpotentialofakr1b1intriplenegativebreastcancer |